First, GLP-1 causes an increase in satiety and a decrease in hunger leading to decreased food intake [11]
These drugs have passed the clinical trials needed to be approved for use in the UK and have been cautiously welcomed by those working to tackle obesity
Some clients use both: for example, Fabulous Drips for hydration and energy, and peptide therapy for skin or recovery
For patients prioritizing cost, access, and personalized optimization, PlexusDx compounded semaglutide at $189/mo month-to-month, or from $149/mo on the 6-month plan represents the most practical entry point into evidence-based GLP-1 weight management
We use advanced diagnostics to understand your unique metabolism, allowing us to create a comprehensive plan that addresses the underlying factors of weight gain, often utilizing powerful treatments like GLP-1 agonists such as Semaglutide
doi: 10.1111/DOM.13935 59 RochoJKalinowskiPGrtMSzymanek-MajchrzakK